IONQ
IONQ
$43.29
+0.74%
IonQ, Inc. is a quantum computing company that sells access to its quantum computers of various qubit capacities, primarily through cloud platforms and its own cloud service, generating revenue from quantum-computing-as-a-service (QCaaS), consulting, and system design contracts. As a pure-play quantum computing company, IonQ is distinct from diversified technology giants, offering investors direct exposure to the emerging quantum computing industry. The current investor narrative is dominated by recent technological breakthroughs, including an error-correction milestone and a collaboration with Nvidia, which have sparked debate about the company's commercial viability and its potential to achieve fault-tolerant quantum computing. Despite these advances, the stock remains highly speculative, with significant losses and a rich valuation, leading to polarized views among analysts and investors.…
IONQ
IONQ
$43.29
Related headlines
Investment Opinion: Should I buy IONQ Today?
Based on the synthesis of data, IonQ warrants a Hold rating with a speculative bias. The core thesis is that while IonQ offers unparalleled exposure to the quantum computing revolution with explosive revenue growth (286.83% YoY in Q2 2026) and a strong balance sheet (current ratio 15.50, debt-to-equity 0.0079), its extreme valuation (PS 96.75) and massive losses ($1.87 billion net loss in Q2 2026) create an unfavorable risk-reward profile at current levels. The analyst consensus is 'strong buy' with an average target of $66.63 (52.2% upside), but the wide target range ($41.85 to $100.00) reflects high uncertainty.
Supporting evidence for the Hold includes: 1) Revenue growth is stellar, but profitability remains elusive with a net margin of -23.33% and operating margin of -4.87%. 2) The balance sheet is robust with minimal debt, but free cash flow is deeply negative at -$483.87 million TTM, necessitating further dilution. 3) The PS ratio of 96.75 is near the low end of its historical range (127.19 to 667.29), suggesting relative undervaluation versus its own history, but still trades at a massive premium to the industry average. 4) The stock has rebounded 49.39% over six months but remains 48.3% below its 52-week high, indicating potential upside if momentum continues.
Key risks that could invalidate the thesis include: 1) Failure to achieve commercial viability or delays in fault-tolerant quantum computing, leading to a cash crunch. 2) Increased competition from tech giants like Microsoft and Alphabet, which could pressure IonQ's market share and pricing. 3) A broader market downturn or sector rotation away from high-growth, unprofitable tech, which could trigger a valuation reset. The rating would upgrade to Buy if IonQ demonstrates a clear path to profitability (e.g., gross margins sustainably above 50% and operating leverage) or if the stock pulls back to a more reasonable valuation (PS below 50). Conversely, a downgrade to Sell would occur if revenue growth decelerates below 100% YoY or if cash burn accelerates without adequate funding. Relative to its history, the stock appears undervalued, but relative to peers and fundamentals, it remains overvalued.
Sign up to view all
IONQ 12-Month Price Forecast
IonQ presents a classic high-risk, high-reward scenario. The company's revenue growth is exceptional, and its technological breakthroughs could revolutionize computing, but it remains deeply unprofitable with significant cash burn. The valuation is rich, but relative to its own history, it is near the low end, suggesting some upside if execution continues. Analyst sentiment is bullish, but the wide target range reflects uncertainty. The extreme volatility makes it unsuitable for risk-averse investors. I would upgrade to bullish if IonQ demonstrates a clear path to profitability or secures major commercial contracts that validate its technology. Conversely, I would downgrade to bearish if revenue growth decelerates sharply or if cash reserves dwindle faster than expected.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $66.63 and implied upside of +53.9% versus the current price.
Average Target
$66.63
0 analysts
Implied Upside
+53.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $100
Analyst target range
The stock is covered by 14 analysts, with a consensus recommendation of "strong buy" (recommendation mean of 1.36). The average target price is $66.63, implying a 52.2% upside from the current price of $43.77. The consensus is bullish, driven by recent technological breakthroughs and partnerships, but the high valuation and lack of profitability keep some analysts cautious. The target price range is wide, from a low of $41.85 to a high of $100.00. The high target assumes successful commercialization of fault-tolerant quantum computing and significant revenue growth, while the low target reflects concerns about execution risks and continued losses. The wide spread indicates high uncertainty and divergent views on the company's future. Institutional ratings show mostly "Buy" or "Neutral" ratings from firms like Benchmark, Goldman Sachs, and Needham, with no recent upgrades or downgrades, suggesting stable but cautious sentiment. The estimated EPS average is -$0.44, with a range of -$0.55 to -$0.36, and estimated revenue average is $1.95 billion, reflecting expectations of continued growth but ongoing losses.
Bulls vs Bears: IONQ Investment Factors
The bull case for IonQ rests on explosive revenue growth (286.83% YoY in Q2 2026), a strong balance sheet with minimal debt, and recent technological breakthroughs that could revolutionize computing. However, the bear case is equally compelling: the stock trades at a sky-high PS ratio of 96.75 despite massive losses, negative free cash flow, and a highly uncertain path to profitability. The extreme volatility (beta 3.295) and significant drawdown risk further complicate the investment case. Currently, the bear evidence appears stronger due to the lack of profitability and the premium valuation, but the bull case could gain traction if IonQ continues to deliver on technological milestones and revenue growth. The single most important tension is whether IonQ can achieve commercial viability and eventually profitability before its cash reserves dwindle or investor patience runs out.
Bullish
- Explosive revenue growth: Q2 2026 revenue surged 286.83% year-over-year to $80.05 million, up from $20.69 million in Q2 2025. This marks the third consecutive quarter of sequential growth, with revenue rising from $61.89 million in Q4 2025 to $64.67 million in Q1 2026 and then to $80.05 million in Q2 2026. The growth is driven by expanding quantum-computing-as-a-service (QCaaS) offerings and system design contracts.
- Strong analyst consensus and upside: 14 analysts cover IonQ with a consensus recommendation of 'strong buy' (mean 1.36) and an average target price of $66.63, implying 52.2% upside from the current price of $43.77. The high target of $100.00 suggests significant optimism about the company's technological breakthroughs and commercial potential.
- Fortress balance sheet: IonQ maintains a current ratio of 15.50 and a debt-to-equity ratio of just 0.0079, indicating minimal leverage and ample liquidity. The company raised $1.95 billion in common stock in Q4 2025, providing substantial funding for its growth initiatives without relying on debt.
- Recent technical momentum: The stock has rebounded 49.39% over the past six months and 16.29% in the last month, outperforming the S&P 500 by 15.70% in the past month. This momentum, driven by recent technological breakthroughs and the Nvidia collaboration, suggests a potential trend reversal from the prior downtrend.
Bearish
- Extreme valuation with no profits: IonQ trades at a PS ratio of 96.75 and an EV/Sales of 59.67, vastly higher than typical technology hardware companies (often below 10). With a forward PE of -33.86 and negative net income, the valuation relies entirely on future growth expectations, leaving little room for error.
- Massive and persistent losses: The company reported a net loss of $1.87 billion in Q2 2026, with a net margin of -23.33% and operating margin of -4.87%. Despite revenue growth, operating expenses remain high, particularly R&D at $160.63 million and SG&A costs, leading to significant cash burn.
- Severe cash burn: Free cash flow is negative at -$483.87 million on a trailing twelve-month basis, and operating cash flow was -$103.76 million in Q2 2026. The company relies on external financing, as evidenced by the $1.95 billion equity issuance in Q4 2025, which dilutes existing shareholders.
- Extreme volatility and drawdown risk: With a beta of 3.295, IonQ is over three times more volatile than the market. The stock has experienced a maximum drawdown of -67.61% and is currently 48.3% below its 52-week high of $84.64, highlighting the potential for severe losses.
IONQ Technical Analysis
IONQ is in a recovery phase within a broader downtrend, with the current price of $43.77 sitting at 30.4% of its 52-week range (52-week low: $25.89, 52-week high: $84.64). The 1-year price change of -37.11% reflects the significant decline from its highs, but the recent 6-month gain of 49.39% indicates a strong rebound from the lows. This positioning suggests that while the stock has momentum, it is still far from its peak, offering potential upside if the recovery continues. Recent momentum is positive, with a 1-month gain of 16.29% and a 3-month decline of 10.89%, showing a sharp reversal from the prior downtrend. The 1-month relative strength versus SPY is +15.70%, indicating outperformance, while the 3-month relative strength is -14.23%, highlighting the recent turnaround. The divergence between the 1-year decline and the 1-month surge suggests a potential trend reversal, but the 3-month negative performance warrants caution. Key technical levels include support at the 52-week low of $25.89 and resistance at the 52-week high of $84.64. A breakout above resistance would signal a new uptrend, while a breakdown below support could resume the bearish trend. The beta of 3.295 indicates extreme volatility, with the stock moving over three times the market's swings, necessitating careful position sizing and risk management. The maximum drawdown of -67.61% further underscores the high-risk nature of this stock.
Beta
3.36
3.36x market volatility
Max Drawdown
-67.6%
Largest decline past year
52-Week Range
$26-$85
Price range past year
Annual Return
-45.2%
Cumulative gain past year
| Period | IONQ Return | S&P 500 |
|---|---|---|
| 1m | +9.5% | +1.2% |
| 3m | -4.0% | +4.5% |
| 6m | +54.2% | +14.6% |
| 1y | -45.2% | +16.0% |
| ytd | -7.4% | +14.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IONQ Fundamental Analysis
Revenue has shown explosive growth, with the most recent quarter (Q2 2026) reporting $80.05 million, a 286.83% increase year-over-year. This follows Q1 2026 revenue of $64.67 million and Q4 2025 revenue of $61.89 million, demonstrating a consistent upward trajectory. The growth is driven by expanding QCaaS offerings and system design contracts, but the company remains unprofitable, with a net loss of $1.87 billion in Q2 2026. The gross margin has been volatile, ranging from 8.46% in Q2 2025 to 56.48% in Q4 2025, and was 24.91% in Q2 2026. The net margin is deeply negative at -23.33% for Q2 2026, reflecting substantial operating expenses, particularly in research and development ($160.63 million) and selling, general and administrative costs. The company's profitability is hindered by heavy investments in technology development, typical for the quantum computing industry, but the path to profitability remains uncertain. The balance sheet is strong with a current ratio of 15.50 and a debt-to-equity ratio of 0.0079, indicating minimal leverage and ample liquidity. However, free cash flow is negative at -$483.87 million on a trailing twelve-month basis, and operating cash flow was -$103.76 million in Q2 2026, highlighting significant cash burn. The company relies on external financing, as evidenced by $1.95 billion in common stock issued in Q4 2025, to fund its growth initiatives. The return on equity is -13.43%, reflecting the ongoing losses and the dilutive impact of equity issuances.
Quarterly Revenue
$80050000.0B
2026-06
Revenue YoY Growth
+286.8%
YoY Comparison
Gross Margin
24.9%
Latest Quarter
Free Cash Flow
$-483868000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IONQ Overvalued?
Since IonQ has negative net income, the PS ratio is the appropriate valuation metric. The current PS ratio is 96.75, which is extremely high, and the forward PE is -33.86, indicating that the company is not expected to be profitable in the near term. The gap between trailing and forward metrics suggests that the market is pricing in significant future growth, but the lack of earnings makes valuation challenging. Compared to the industry average, IonQ's PS ratio of 96.75 is substantially higher than typical technology hardware companies, which often trade at PS ratios below 10. This premium is likely justified by the company's explosive revenue growth and leadership in quantum computing, but it also reflects the high risk and uncertainty. The EV/Sales ratio of 59.67 further emphasizes the premium valuation. Historically, IonQ's PS ratio has been volatile, ranging from 127.19 in Q2 2024 to 667.29 in Q1 2025, and currently at 96.75, which is near the lower end of its historical range. This could indicate that the stock is relatively undervalued compared to its own history, but the absolute level remains elevated, suggesting that the market still has high expectations for future growth.
PE
-24.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-24.4x
Enterprise Value Multiple
Investment Risk Disclosure
IonQ faces significant financial and operational risks. The company is deeply unprofitable, with a net loss of $1.87 billion in Q2 2026 and a net margin of -23.33%. Despite explosive revenue growth of 286.83% year-over-year, operating expenses remain high, particularly R&D at $160.63 million and SG&A costs, leading to substantial cash burn. Free cash flow is negative at -$483.87 million on a trailing twelve-month basis, and operating cash flow was -$103.76 million in Q2 2026. The company relies on external financing, as evidenced by the $1.95 billion equity issuance in Q4 2025, which dilutes shareholders and highlights the need for continued capital raises. Additionally, revenue is concentrated in a few contracts and QCaaS offerings, making it vulnerable to customer concentration and contract renewals.
Market and competitive risks are also pronounced. IonQ trades at a PS ratio of 96.75, far above the industry average of below 10, leaving it susceptible to valuation compression if growth slows or market sentiment shifts. The quantum computing space is highly competitive, with tech giants like Microsoft, Alphabet, and IBM investing heavily, which could erode IonQ's market share. The stock's beta of 3.295 indicates extreme volatility, moving over three times the market's swings, making it sensitive to macroeconomic factors such as interest rate changes and sector rotation. Recent news highlights the debate between IonQ's high-risk, high-reward profile and safer, diversified alternatives like Microsoft, underscoring the competitive pressures.
In a worst-case scenario, IonQ could fail to commercialize its technology or face delays in achieving fault-tolerant quantum computing, leading to a cash crunch and further equity dilution. The stock could plummet to its 52-week low of $25.89, representing a 40.8% decline from the current price of $43.77. If the company's technology proves less viable than competitors' or if a major contract is lost, the analyst low target of $41.85 might be breached, and the stock could revisit historical lows. Given the maximum drawdown of -67.61%, investors could lose over two-thirds of their investment in a severe downturn.
FAQ
The key risks include: 1) Financial risk: massive losses ($1.87 billion net loss in Q2 2026) and negative free cash flow (-$483.87 million TTM) require ongoing external financing, leading to dilution. 2) Competitive risk: tech giants like Microsoft and Alphabet are investing heavily in quantum computing, which could erode IonQ's market share. 3) Valuation risk: the PS ratio of 96.75 is extremely high, and any slowdown in growth could trigger a sharp correction. 4) Macro risk: with a beta of 3.295, the stock is highly sensitive to market downturns and interest rate changes. The most severe risk is a failure to commercialize its technology, which could lead to a cash crunch and a stock price collapse.
Our 12-month forecast presents three scenarios: Bull case (25% probability) targets $84.64-$100.00, driven by successful technology commercialization and major partnerships. Base case (50% probability) targets $55.00-$70.00, assuming continued revenue growth but ongoing losses. Bear case (25% probability) targets $25.89-$41.85, reflecting execution failures or funding challenges. The base case is most likely, hinging on IonQ maintaining revenue growth above 100% YoY while gradually narrowing losses. Analyst average target of $66.63 aligns with the base case.
IonQ appears overvalued on absolute metrics but relatively undervalued compared to its own history. The PS ratio of 96.75 is far above the industry average of below 10, and the EV/Sales of 59.67 is also elevated. However, the PS ratio is near the low end of its historical range (127.19 to 667.29), suggesting that the market has already priced in a significant correction. The forward PE of -33.86 indicates no near-term earnings, so valuation relies entirely on future growth. The market is pricing in explosive growth and eventual profitability, leaving little margin for error.
Whether IonQ is a good buy depends on your risk tolerance and investment horizon. The stock has a strong buy consensus from 14 analysts with an average target of $66.63, implying 52.2% upside, and revenue is growing at 286.83% YoY. However, the company is unprofitable with a net loss of $1.87 billion in Q2 2026, and the PS ratio of 96.75 is extremely high. The extreme volatility (beta 3.295) and potential for further dilution make it a high-risk bet. For aggressive investors seeking exposure to quantum computing, a small position could be justified, but conservative investors should avoid it.
IonQ is more suitable for long-term investment by risk-tolerant investors, given its early-stage growth profile and the multi-year horizon for quantum computing commercialization. The stock's extreme volatility (beta 3.295) and lack of dividends make it unsuitable for short-term trading unless one is a speculator. A minimum holding period of 3-5 years is recommended to ride out potential drawdowns and allow for technological maturation. Short-term traders might capitalize on momentum, but the high risk of sudden reversals (max drawdown -67.61%) makes it dangerous. Long-term investors should size positions carefully and be prepared for further dilution.